Vanadium and proteins: Uptake, transport, structure, activity and function

Abstract Vanadium is an element ubiquitously present in our planet's crust and thus there are several organisms that use vanadium for activity or function of proteins. Examples are the vanadium-dependent haloperoxidases and the vanadium-containing nitrogenases. Some organisms that use vanadium have extremely efficient and selective protein-dependent systems for uptake and transport of vanadium and are able to accumulate high levels of vanadium from seawater, vanabins being a unique family of vanadium binding proteins found in ascidians involved in this process. For all of the systems a discussion regarding the role of the V-containing proteins is provided, mostly centered on structural aspects of the vanadium site and, when possible or relevant, relating this to the mechanisms operating. Phosphate is very important in biological systems and is involved in an extensive number of biological recognition and bio-catalytic systems. Vanadate(V) is able to inhibit many of the enzymes involved in these processes, such as ATPases, phosphatases, ribonucleases, phosphodiesterases, phosphoglucomutase and glucose-6-phosphatase, and it appears clear that this is closely related to the analogous physicochemical properties of vanadate and phosphate. The ability of vanadium to interfere with the metabolic processes involving Ca2+ and Mg2+, connected with its versatility to undergo changes in coordination geometry, allow V to influence the function of a large variety of phosphate-metabolizing enzymes and vanadate(V) salts and compounds have been frequently used either as inhibitors of these enzymes, or as probes to study the mechanisms of their reactions and catalytic cycle. In this review we give an overview of the many examples so far reported, also disclosing that vanadate(IV) may also have an equally efficient inhibiting effect. The prospective application of vanadium compounds as therapeutics has also been an important topic of research. How vanadium may be transported in blood and up-taken by cells are particularly relevant issues, this being mainly dependent on transferrin (and albumin) present in blood plasma. The thousands of studies reported on the effects of vanadium compounds reflect the complexity of the interactions occurring. Although it is not easy to anticipate/determine if a particular effect observed in a test tube or in vitro is also going to take place in vivo, it is clear that vanadium ions may interfere with many metabolic processes at many distinct levels. Emphasis is given on structural and functional aspects of vanadium–protein interactions relevant for vanadium binding and/or for clarification of role of the metal center in the reaction mechanisms. The additional knowledge that the presence of vanadium can change the action of a protein, other than simply inhibiting it, may also be important to understand how vanadium affects biological systems. This possibility, together with the vanadate–phosphate analogy further potentiates the belief that vanadium probably has relevant functions in living beings, which may involve interaction or incorporation of the metal ion and/or its compounds with several proteins.

[1]  A. Sanz-Medel,et al.  Biospeciation of various antidiabetic V(IV)O compounds in serum. , 2009, Dalton transactions.

[2]  W. M. Huang,et al.  An interlocked dimer of the protelomerase TelK distorts DNA structure for the formation of hairpin telomeres. , 2007, Molecular cell.

[3]  Processive steps in the reverse direction require uncoupling of the lead head lever arm of myosin VI. , 2012, Molecular cell.

[4]  P. Sadler,et al.  Multi-metal binding site of serum albumin. , 1998, Journal of inorganic biochemistry.

[5]  P. Pedersen,et al.  Mitochondrial ATP Synthase , 2006, Journal of Biological Chemistry.

[6]  D. Crans,et al.  Trigonal Bipyramidal or Square Pyramidal Coordination Geometry? Investigating the Most Potent Geometry for Vanadium Phosphatase Inhibitors , 2014 .

[7]  H. Dar,et al.  Intermolecular phosphotransfer is crucial for efficient catalytic activity of nucleoside diphosphate kinase. , 2010, The Biochemical journal.

[8]  Nicole M. Baker,et al.  Structural studies of type I topoisomerases , 2008, Nucleic acids research.

[9]  Hiroyuki Noji,et al.  Rotation and structure of FoF1-ATP synthase. , 2011, Journal of biochemistry.

[10]  K. Hodgson,et al.  Characterization of isolated nitrogenase FeVco. , 2010, Journal of the American Chemical Society.

[11]  B. Golden Two distinct catalytic strategies in the hepatitis δ virus ribozyme cleavage reaction. , 2011, Biochemistry.

[12]  Robert J.P. Williams,et al.  The Natural Selection of the Chemical Elements: The Environment and Life's Chemistry , 1997 .

[13]  T. Kiss,et al.  A novel V(IV)O-pyrimidinone complex: synthesis, solution speciation and human serum protein binding. , 2013, Dalton transactions.

[14]  Isabelle Bougie,et al.  Inhibition of a metal-dependent viral RNA triphosphatase by decavanadate. , 2006, The Biochemical journal.

[15]  Richard J. Kuhn,et al.  Structure of the Flavivirus Helicase: Implications for Catalytic Activity, Protein Interactions, and Proteolytic Processing , 2005, Journal of Virology.

[16]  Benjamin J Peters,et al.  Vanadium–phosphatase complexes: Phosphatase inhibitors favor the trigonal bipyramidal transition state geometries , 2015 .

[17]  S. Nehring,et al.  Structural basis for DNA duplex separation by a superfamily-2 helicase , 2007, Nature Structural &Molecular Biology.

[18]  M. Page,et al.  Serine peptidases: Classification, structure and function , 2008, Cellular and Molecular Life Sciences.

[19]  G. Micera,et al.  On the prediction of 51V hyperfine coupling constants in V(IV)O complexes through DFT methods. , 2009, Dalton transactions.

[20]  V. Guliants Structure–reactivity relationships in oxidation of C4 hydrocarbons on supported vanadia catalysts , 1999 .

[21]  Giovanni Micera,et al.  Is the spin‐orbit coupling important in the prediction of the 51V hyperfine coupling constants of VIVO2+ species? ORCA versus Gaussian performance and biological applications , 2011, J. Comput. Chem..

[22]  J. Champoux,et al.  Insights into substrate binding and catalytic mechanism of human tyrosyl-DNA phosphodiesterase (Tdp1) from vanadate and tungstate-inhibited structures. , 2002, Journal of molecular biology.

[23]  G. Murshudov,et al.  Crystal structure of dodecameric vanadium-dependent bromoperoxidase from the red algae Corallina officinalis. , 2000, Journal of molecular biology.

[24]  D. Singel,et al.  Characterization of the ligand environment of vanadyl complexes of apoferritin by multifrequency electron spin-echo envelope modulation , 1991 .

[25]  I. Bertini,et al.  Spectral characterization of vanadium-transferrin systems. , 1985, Journal of inorganic biochemistry.

[26]  A. Lange,et al.  Bromoperoxidase activity of vanadate-substituted acid phosphatases from Shigella flexneri and Salmonella enterica ser. typhimurium. , 2002, European journal of biochemistry.

[27]  The role of the C-terminal region in phosphoglycerate mutase. , 1999 .

[28]  T. Kiss,et al.  The speciation of vanadium in human serum , 2011 .

[29]  L. Cantley,et al.  The fate of cytoplasmic vanadium. Implications on (NA,K)-ATPase inhibition. , 1979, The Journal of biological chemistry.

[30]  F. Marceau,et al.  NTPDase1 (CD39) controls nucleotide-dependent vasoconstriction in mouse. , 2010, Cardiovascular research.

[31]  Alfonso Mondragón,et al.  Emerging structural themes in large RNA molecules. , 2011, Current opinion in structural biology.

[32]  P. Pedersen,et al.  Ion motive ATPases. I. Ubiquity, properties, and significance to cell function , 1987 .

[33]  W. Vogt,et al.  Binding of vanadate to human albumin in infusion solutions, to proteins in human fresh frozen plasma, and to transferrin. , 2002, Journal of inorganic biochemistry.

[34]  D. Fairlie,et al.  Update 1 of: Proteases universally recognize beta strands in their active sites. , 2010, Chemical reviews.

[35]  Susan M. Schelble,et al.  Vanadate dimer and tetramer both inhibit glucose-6-phosphate dehydrogenase from Leuconostoc mesenteroides. , 1990, Biochemistry.

[36]  Florian Odronitz,et al.  Drawing the tree of eukaryotic life based on the analysis of 2,269 manually annotated myosins from 328 species , 2007, Genome Biology.

[37]  E. Garman,et al.  A complex iron-calcium cofactor catalyzing phosphotransfer chemistry , 2014, Science.

[38]  J. McNeill,et al.  Vanadium treatment of type 2 diabetes: a view to the future. , 2009, Journal of inorganic biochemistry.

[39]  J. Champoux,et al.  Crystal structures of human topoisomerase I in covalent and noncovalent complexes with DNA. , 1998, Science.

[40]  C. Campa,et al.  X-ray studies on ternary complexes of maltodextrin phosphorylase. , 2008, Archives of biochemistry and biophysics.

[41]  R. Wever,et al.  Kinetic characterization of active site mutants Ser402Ala and Phe397His of vanadium chloroperoxidase from the fungus Curvularia inaequalis , 2003 .

[42]  T. Nakae,et al.  Subunit structure of functional porin oligomers that form permeability channels in the other membrane of Escherichia coli. , 1979, The Journal of biological chemistry.

[43]  T. Otake,et al.  Discovery of a new vanadium accumulator, the fan wormPseudopotamilla occelata , 1993, Naturwissenschaften.

[44]  J. Quinn,et al.  Divergence of chemical function in the alkaline phosphatase superfamily: structure and mechanism of the P-C bond cleaving enzyme phosphonoacetate hydrolase. , 2011, Biochemistry.

[45]  R. Crichton Inorganic Biochemistry of Iron Metabolism: From Molecular Mechanisms to Clinical Consequences , 2001 .

[46]  B. K. Hodnett Vanadium-phosphorus Oxide Catalysts for the Selective Oxidation of C-4 Hydrocarbons To Maleic-anhydride , 1985 .

[47]  M. Percival,et al.  Inhibition of phosphoglucomutase by vanadate. , 1990, Biochemistry.

[48]  R. Raines,et al.  Value of general Acid-base catalysis to ribonuclease a. , 1994, Journal of the American Chemical Society.

[49]  G. Micera,et al.  Biotransformation of BMOV in the presence of blood serum proteins. , 2012, Metallomics : integrated biometal science.

[50]  J. K. Grady,et al.  Vanadium complexes of transferrin and ferritin in the rat. , 1986, Biochimica et biophysica acta.

[51]  R. Sheldon,et al.  Biocatalytic and biomimetic oxidations with vanadium. , 2000, Journal of inorganic biochemistry.

[52]  V. Pecoraro,et al.  Synthetic and computational modeling of the vanadium-dependent haloperoxidases , 2005 .

[53]  W. R. Harris,et al.  Thermodynamics of anion binding to human serum transferrin. , 1985, Biochemistry.

[54]  R. Pratt,et al.  Inhibition of serine amidohydrolases by complexes of vanadate with hydroxamic acids. , 2000, Biochemical and biophysical research communications.

[55]  D. Manstein,et al.  Inhibition of Myosin ATPase activity by halogenated pseudilins: a structure-activity study. , 2011, Journal of medicinal chemistry.

[56]  L. Hedstrom Serine protease mechanism and specificity. , 2002, Chemical reviews.

[57]  G. F. Fuhrmann,et al.  Effects of vanadate on intracellular reduction equivalents in mouse liver and the fate of vanadium in plasma, erythrocytes and liver. , 1984, Toxicology.

[58]  H. Sakurai,et al.  Binding constant of VIVO to transferrin , 2006 .

[59]  Dagmar Ringe,et al.  Inhibition of chymotrypsin by a complex of ortho-vanadate and benzohydroxamic acid: structure of the inert complex and its mechanistic interpretation. , 2007, Biochemistry.

[60]  M. Dilworth,et al.  Hydrazine is a product of dinitrogen reduction by the vanadium-nitrogenase from Azotobacter chroococcum. , 1991, The Biochemical journal.

[61]  S. Rubinstein,et al.  Remodeling of the Actin Cytoskeleton During Mammalian Sperm Capacitation and Acrosome Reaction1 , 2003, Biology of reproduction.

[62]  António J. M. Ribeiro,et al.  The catalytic mechanism of protein phosphatase 5 established by DFT calculations. , 2013, Chemistry.

[63]  R. Rodenburg,et al.  Mitochondrial ATP synthase: architecture, function and pathology , 2011, Journal of Inherited Metabolic Disease.

[64]  James R. Williamson,et al.  The catalytic diversity of RNAs , 2005, Nature Reviews Molecular Cell Biology.

[65]  Wei Yang,et al.  Crystal Structures of RNase H Bound to an RNA/DNA Hybrid: Substrate Specificity and Metal-Dependent Catalysis , 2005, Cell.

[66]  L. Brunel,et al.  High-Frequency Electron Paramagnetic Resonance Studies of VO2+ in Low-Temperature Glasses , 1999 .

[67]  Wolfgang Jahnke,et al.  Insights into RNA unwinding and ATP hydrolysis by the flavivirus NS3 protein , 2008, The EMBO journal.

[68]  A. Wlodawer,et al.  Structure of phosphate-free ribonuclease A refined at 1.26 A. , 1988, Biochemistry.

[69]  P. Myler,et al.  An ensemble of structures of Burkholderia pseudomallei 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase , 2011, Acta crystallographica. Section F, Structural biology and crystallization communications.

[70]  J. McGrath,et al.  The purification and properties of phosphonoacetate hydrolase, a novel carbon-phosphorus bond-cleavage enzyme from Pseudomonas fluorescens 23F. , 1995, European journal of biochemistry.

[71]  A. D. Gen,et al.  A Horner-Wittig Synthesis of 1-Chlorovinyl Sulfoxides. , 1996 .

[72]  Yilin Hu,et al.  Extending the Carbon Chain: Hydrocarbon Formation Catalyzed by Vanadium/Molybdenum Nitrogenases , 2011, Science.

[73]  R. Hamilton,et al.  Human IgG subclass measurements in the clinical laboratory. , 1987, Clinical chemistry.

[74]  Binding of VIVO2+ to the Fe binding sites of human serum transferrin. A theoretical study , 2013, JBIC Journal of Biological Inorganic Chemistry.

[75]  Peter J Sadler,et al.  Albumin as a zinc carrier: properties of its high-affinity zinc-binding site. , 2008, Biochemical Society transactions.

[76]  J. Littlechild,et al.  Structural and functional comparisons between vanadium haloperoxidase and acid phosphatase enzymes , 2002, Journal of molecular recognition : JMR.

[77]  M. Karin,et al.  Mammalian MAP kinase signalling cascades , 2001, Nature.

[78]  G. Yegutkin Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade. , 2008, Biochimica et biophysica acta.

[79]  T. Ueki,et al.  Vanadium-binding proteins (vanabins) from a vanadium-rich ascidian Ascidia sydneiensis samea. , 2003, Biochimica et biophysica acta.

[80]  C. Rithner,et al.  Application of time-resolved vanadium-51 2D NMR for quantitation of kinetic exchange pathways between vanadate monomer, dimer, tetramer, and pentamer , 1990 .

[81]  G. C. Levy,et al.  51V-n.m.r. analysis of the binding of vanadium(V) oligoanions to sarcoplasmic reticulum. , 1985, The Biochemical journal.

[82]  J. Iqbal,et al.  Therapeutic Potentials of Ecto‐Nucleoside Triphosphate Diphosphohydrolase, Ecto‐Nucleotide Pyrophosphatase/Phosphodiesterase, Ecto‐5′‐Nucleotidase, and Alkaline Phosphatase Inhibitors , 2014, Medicinal research reviews.

[83]  J. Quinn,et al.  Cloning of the phosphonoacetate hydrolase gene from Pseudomonas fluorescens 23F encoding a new type of carbon-phosphorus bond cleaving enzyme and its expression in Escherichia coli and Pseudomonas putida. , 1997, Gene.

[84]  N. Chasteen The biochemistry of vanadium , 1983 .

[85]  B. Foth,et al.  New insights into myosin evolution and classification. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[86]  M. Bangesh,et al.  TD-DFT studies on the electronic structure of imidazole bound vanadate in vanadium containing haloperoxidases (VHPO) , 2005 .

[87]  Kui Wang,et al.  Membrane transport of vanadium compounds and the interaction with the erythrocyte membrane , 2003 .

[88]  G. Mocz,et al.  Vanadate Sensitized Photocleavage of Proteins , 1990 .

[89]  A. Goldfine,et al.  Effect of vanadium(IV) compounds in the treatment of diabetes: in vivo and in vitro studies with vanadyl sulfate and bis(maltolato)oxovandium(IV). , 2001, Journal of inorganic biochemistry.

[90]  J. Littlechild,et al.  Enhancing effect of calcium and vanadium ions on thermal stability of bromoperoxidase from Corallina pilulifera , 2005, JBIC Journal of Biological Inorganic Chemistry.

[91]  S. Macedo-Ribeiro,et al.  X-ray crystal structures of active site mutants of the vanadium-containing chloroperoxidase from the fungus Curvularia inaequalis , 1999, JBIC Journal of Biological Inorganic Chemistry.

[92]  T. Ueki,et al.  Molecular mechanism of the transport and reduction pathway of vanadium in ascidians , 2011 .

[93]  K. Föhr,et al.  Characterization of the inositol 1,4,5-trisphosphate-induced calcium release from permeabilized endocrine cells and its inhibition by decavanadate and p-hydroxymercuribenzoate. , 1989, The Biochemical journal.

[94]  P. Aisen,et al.  Stoichiometric and site characteristics of the binding of iron to human transferrin. , 1978, The Journal of biological chemistry.

[95]  I. Baranowska-Bosiacka,et al.  Biochemical and medical importance of vanadium compounds. , 2012, Acta biochimica Polonica.

[96]  D. Gefel,et al.  Historic perspective and recent developments on the insulin-like actions of vanadium; toward developing vanadium-based drugs for diabetes , 2003 .

[97]  K. Hodgson,et al.  The uptake and fate of vanadyl ion in ascidian blood cells and a detailed hypothesis for the mechanism and location of biological vanadium reduction. A visible and X-ray absorption spectroscopic study. , 2008, Journal of inorganic biochemistry.

[98]  S. Everse,et al.  How the binding of human transferrin primes the transferrin receptor potentiating iron release at endosomal pH , 2011, Proceedings of the National Academy of Sciences.

[99]  D. Rehder Bioinorganic Vanadium Chemistry , 2008 .

[100]  A. Casini,et al.  Mechanistic studies on two dinuclear organogold(III) compounds showing appreciable antiproliferative properties and a high redox stability. , 2011, Metallomics : integrated biometal science.

[101]  T. Kunkel,et al.  Aprataxin resolves adenylated RNA-DNA junctions to maintain genome integrity , 2013, Nature.

[102]  D. Dunaway-Mariano,et al.  The catalytic scaffold of the haloalkanoic acid dehalogenase enzyme superfamily acts as a mold for the trigonal bipyramidal transition state , 2008, Proceedings of the National Academy of Sciences.

[103]  P. Pedersen,et al.  Chemical Mechanism of ATP Synthase , 1999, The Journal of Biological Chemistry.

[104]  G. Micera,et al.  Uptake of potential anti-diabetic VIVO compounds of picolinate ligands by red blood cells , 2014 .

[105]  J. Champoux DNA topoisomerases: structure, function, and mechanism. , 2001, Annual review of biochemistry.

[106]  J. Dixon,et al.  Visualization of intermediate and transition-state structures in protein-tyrosine phosphatase catalysis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[107]  Timothy D. Fenn,et al.  Structural and functional comparisons of nucleotide pyrophosphatase/phosphodiesterase and alkaline phosphatase: implications for mechanism and evolution. , 2006, Biochemistry.

[108]  J. Janin,et al.  Three-Dimensional Structure of Nucleoside Diphosphate Kinase , 2000, Journal of bioenergetics and biomembranes.

[109]  Yilin Hu,et al.  Radical SAM-Dependent Carbon Insertion into the Nitrogenase M-Cluster , 2012, Science.

[110]  H. Akiyama,et al.  Binding patterns of vanadium to transferrin in healthy human serum studied with HPLC/high resolution ICP-MS. , 2004, The Analyst.

[111]  V. Müller,et al.  ATP synthases from archaea: the beauty of a molecular motor. , 2014, Biochimica et biophysica acta.

[112]  W. Casey,et al.  Sarcoplasmic reticulum calcium ATPase interactions with decaniobate, decavanadate, vanadate, tungstate and molybdate. , 2012, Journal of inorganic biochemistry.

[113]  Michael G. Davis,et al.  Mechanism of insulin sensitization by BMOV (bis maltolato oxo vanadium); unliganded vanadium (VO4) as the active component. , 2003, Journal of inorganic biochemistry.

[114]  Sean J. Johnson,et al.  Insights into the Reaction of Protein-tyrosine Phosphatase 1B , 2010, The Journal of Biological Chemistry.

[115]  Hiromu Sakurai,et al.  Antidiabetic vanadium(IV) and zinc(II) complexes , 2002 .

[116]  V. Van Hoof,et al.  Interpretation and clinical significance of alkaline phosphatase isoenzyme patterns. , 1994, Critical reviews in clinical laboratory sciences.

[117]  C. W. Peterson,et al.  On the evolutionary significance and metal-binding characteristics of a monolobal transferrin from Ciona intestinalis , 2008, Proceedings of the National Academy of Sciences.

[118]  D A Winkelmann,et al.  Three-dimensional structure of myosin subfragment-1: a molecular motor. , 1993, Science.

[119]  Irini Akritopoulou-Zanze,et al.  Kinase-targeted libraries: the design and synthesis of novel, potent, and selective kinase inhibitors. , 2009, Drug discovery today.

[120]  H. Yokosawa,et al.  Isolation, characterization and cDNA cloning of a one-lobed transferrin from the ascidian Halocynthia roretzi. , 2001, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology.

[121]  W. M. Huang,et al.  An Enzyme-Catalyzed Multistep DNA Refolding Mechanism in Hairpin Telomere Formation , 2013, PLoS biology.

[122]  S. West,et al.  Molecular Mechanism of DNA Deadenylation by the Neurological Disease Protein Aprataxin* , 2008, Journal of Biological Chemistry.

[123]  G. Gilliland,et al.  X-ray structure of a ribonuclease A-uridine vanadate complex at 1.3 A resolution. , 1997, Acta crystallographica. Section D, Biological crystallography.

[124]  Hiromu Sakurai,et al.  Current state for the development of metallopharmaceutics and anti-diabetic metal complexes. , 2008, Chemical Society reviews.

[125]  N. Sträter,et al.  Crystallographic snapshots along the reaction pathway of nucleoside triphosphate diphosphohydrolases. , 2013, Structure.

[126]  H. Sakurai,et al.  Pharmacokinetic study and trial for preparation of enteric-coated capsule containing insulinomimetic vanadyl compounds: implications for clinical use. , 2003, Mini reviews in medicinal chemistry.

[127]  W. Brill,et al.  Isolation of an iron-molybdenum cofactor from nitrogenase. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[128]  Marcos A. Villarreal,et al.  Vanadate inhibits the ATPase activity and DNA binding capability of bacterial MutS. A structural model for the vanadate-MutS interaction at the Walker A motif. , 2002, Nucleic acids research.

[129]  Z. Sauna,et al.  Functionally Similar Vanadate-induced 8-Azidoadenosine 5′-[α-32P]Diphosphate-trapped Transition State Intermediates of Human P-glycoprotein Are Generated in the Absence and Presence of ATP Hydrolysis* , 2001, The Journal of Biological Chemistry.

[130]  K. Rubinson,et al.  The transport and accumulation of oxyvanadium compounds in human erythrocytes in vitro. , 1982, The Journal of laboratory and clinical medicine.

[131]  C. Kimblin,et al.  Modeling the catalytic site of vanadium bromoperoxidase: synthesis and structural characterization of intramolecularly H-bonded vanadium(V) oxoperoxo complexes, [VO(O(2))((NH)2pyg(2))]K and [VO(O(2))((BrNH)2pyg(2))]K. , 2002, Inorganic chemistry.

[132]  Jaqueline D. Hooker,et al.  Inhibition of acid, alkaline, and tyrosine (PTP1B) phosphatases by novel vanadium complexes. , 2010, Journal of inorganic biochemistry.

[133]  M. A. Nesmeyanova,et al.  Phosphonates and Their Degradation by Microorganisms , 2002, Biochemistry (Moscow).

[134]  C. Carrano,et al.  Binding of vanadate to human serum transferrin. , 1984, Journal of inorganic biochemistry.

[135]  H. Vogel,et al.  Metal-ion binding properties of the transferrins: a vanadium-51 NMR study. , 1996, Journal of inorganic biochemistry.

[136]  Karen N. Allen,et al.  Structure-Function Analysis of 2-Keto-3-deoxy-D-glycero-D-galactonononate-9-phosphate Phosphatase Defines Specificity Elements in Type C0 Haloalkanoate Dehalogenase Family Members* , 2009, Journal of Biological Chemistry.

[137]  J. Moura,et al.  Recent advances into vanadyl, vanadate and decavanadate interactions with actin. , 2012, Metallomics : integrated biometal science.

[138]  J. Pessoa Thirty years through vanadium chemistry. , 2015 .

[139]  K. Kustin,et al.  Vanadium : a biologically relevant element , 1990 .

[140]  R. Wever,et al.  A new model for the membrane topology of glucose‐6‐phosphatase: the enzyme involved in von Gierke disease , 1997, FEBS letters.

[141]  M. Newcomer,et al.  Crystal Structure of Fosfomycin Resistance Kinase FomA from Streptomyces wedmorensis* , 2008, Journal of Biological Chemistry.

[142]  K. Williams,et al.  The determination of dissolved and particulate vanadium in sea water by x-ray fluorescence spectrometry , 1983 .

[143]  F. Quiocho,et al.  Trapping the transition state of an ATP-binding cassette transporter: evidence for a concerted mechanism of maltose transport. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[144]  Thomas A. Richards,et al.  Evolution and Classification of Myosins, a Paneukaryotic Whole-Genome Approach , 2014, Genome biology and evolution.

[145]  J. Montreuil,et al.  Comparative study of the iron-binding properties of human transferrins. II. Electron paramagnetic resonance of mixed metal complexes of human lactotransferrin. , 1983, Biochimica et Biophysica Acta.

[146]  Katherine H Thompson,et al.  Vanadium in diabetes: 100 years from Phase 0 to Phase I. , 2006, Journal of inorganic biochemistry.

[147]  Subhash G. Vasudevan,et al.  Structure of the Dengue Virus Helicase/Nucleoside Triphosphatase Catalytic Domain at a Resolution of 2.4 Å , 2005, Journal of Virology.

[148]  M. Aureliano,et al.  Decavanadate in vitro and in vivo effects: facts and opinions. , 2014, Journal of inorganic biochemistry.

[149]  G. Micera,et al.  Interaction of antidiabetic vanadium compounds with hemoglobin and red blood cells and their distribution between plasma and erythrocytes. , 2014, Inorganic chemistry.

[150]  E. E. Kim,et al.  Reaction mechanism of alkaline phosphatase based on crystal structures. Two-metal ion catalysis. , 1991, Journal of molecular biology.

[151]  M. Fedor,et al.  Structure and function of the hairpin ribozyme. , 2000, Journal of molecular biology.

[152]  G. Micera,et al.  Interaction of VO2+ ion with human serum transferrin and albumin. , 2009, Journal of inorganic biochemistry.

[153]  M. J. Jedrzejas,et al.  Structure, function, and evolution of phosphoglycerate mutases: comparison with fructose-2,6-bisphosphatase, acid phosphatase, and alkaline phosphatase. , 2000, Progress in biophysics and molecular biology.

[154]  M. Aureliano,et al.  Decavanadate effects in biological systems. , 2005, Journal of inorganic biochemistry.

[155]  J. Hartung,et al.  Parameters for bromination of pyrroles in bromoperoxidase-catalyzed oxidations , 2011 .

[156]  Douglas C. Rees,et al.  The E. coli BtuCD Structure: A Framework for ABC Transporter Architecture and Mechanism , 2002, Science.

[157]  I. G. Fantus,et al.  Peroxovanadium compounds. A new class of potent phosphotyrosine phosphatase inhibitors which are insulin mimetics. , 1994, The Journal of biological chemistry.

[158]  J. Vincent,et al.  Low pH binding of vanadyl to bovine lactoferrin , 1979, FEBS letters.

[159]  Katherine H Thompson,et al.  Metal complexes in medicinal chemistry: new vistas and challenges in drug design. , 2006, Dalton transactions.

[160]  M. Fedor Comparative enzymology and structural biology of RNA self-cleavage. , 2009, Annual review of biophysics.

[161]  K. Schwarz,et al.  Growth Effects of Vanadium in the Rat , 1971, Science.

[162]  D. Fattorini,et al.  Hyper-Accumulation of Vanadium in Polychaetes , 2012 .

[163]  T. Maitani,et al.  Binding patterns of vanadium ions with different valence states to human serum transferrin studied by HPLC/high-resolution ICP-MS. , 2002, Biochemical and biophysical research communications.

[164]  A. Burgin,et al.  A eukaryotic enzyme that can disjoin dead-end covalent complexes between DNA and type I topoisomerases. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[165]  J. Tainer,et al.  Crystal structure of the human cell cycle protein CksHs1: single domain fold with similarity to kinase N-lobe domain. , 1995, Journal of molecular biology.

[166]  A. Tracey,et al.  Vanadium(V) oxyanions: the interaction of vanadate with pyrophosphate, phosphate, and arsenate , 1986 .

[167]  N. Sträter,et al.  Structural insight into signal conversion and inactivation by NTPDase2 in purinergic signaling , 2008, Proceedings of the National Academy of Sciences.

[168]  J. Rodrigues,et al.  Unveiling the Interaction of Vanadium Compounds with Human Serum Albumin by Using 1H STD NMR and Computational Docking Studies , 2013 .

[169]  G. Micera,et al.  Binding of Oxovanadium(IV) to Tripeptides Containing Histidine and Cysteine Residues and Its Biological Implication in the Transport of Vanadium and Insulin‐Mimetic Compounds , 2005 .

[170]  D. Barford,et al.  Structural basis for phosphotyrosine peptide recognition by protein tyrosine phosphatase 1B. , 1995, Science.

[171]  K. Brew,et al.  The primary structure of human serum transferrin. The structures of seven cyanogen bromide fragments and the assembly of the complete structure. , 1983, The Journal of biological chemistry.

[172]  L. Pedersen,et al.  Crystal structure of estrogen sulphotransferase , 1997, Nature Structural Biology.

[173]  D. Rehder Is vanadium a more versatile target in the activity of primordial life forms than hitherto anticipated? , 2008, Organic & biomolecular chemistry.

[174]  N. Chasteen Human serotransferrin: structure and function , 1977 .

[175]  D. Crans,et al.  Decavanadate (V10 O28 6-) and oxovanadates: oxometalates with many biological activities. , 2009, Journal of inorganic biochemistry.

[176]  E. Tajkhorshid,et al.  Structural basis for iron piracy by pathogenic Neisseria , 2012, Nature.

[177]  D. Gambino Potentiality of vanadium compounds as anti-parasitic agents , 2011 .

[178]  H. Michibata,et al.  Isolation of highly acidic and vanadium-containing blood cells from among several types of blood cell from Ascidiidae species by density-gradient centrifugation , 1991 .

[179]  D. Schomburg,et al.  X-ray structure determination of a vanadium-dependent haloperoxidase from Ascophyllum nodosum at 2.0 A resolution. , 1999, Journal of molecular biology.

[180]  G. Grüber,et al.  The transition-like state and Pi entrance into the catalytic a subunit of the biological engine A-ATP synthase. , 2011, Journal of molecular biology.

[181]  T. Kiss,et al.  Evaluation of the binding of oxovanadium(IV) to human serum albumin. , 2012, Dalton transactions.

[182]  J. Hartung,et al.  Bromoperoxidases and functional enzyme mimics as catalysts for oxidative bromination—A sustainable synthetic approach , 2011 .

[183]  K. Peters,et al.  Engineering the catalytic domain of human protein tyrosine phosphatase beta for structure-based drug discovery. , 2006, Acta crystallographica. Section D, Biological crystallography.

[184]  S. Yokoyama,et al.  Solution structure of Vanabin2, a vanadium(IV)-binding protein from the vanadium-rich ascidian Ascidia sydneiensis samea. , 2005, Journal of the American Chemical Society.

[185]  João Costa Pessoa,et al.  Vanadium Complexes as Prospective Therapeutics: Structural Characterization of a V(Iv) Lysozyme Adduct , 2014 .

[186]  M. Newcomer,et al.  Structural and biochemical insights into the mechanism of fosfomycin phosphorylation by fosfomycin resistance kinase FomA. , 2011, Biochemistry.

[187]  B. Brenner,et al.  The mechanism of pentabromopseudilin inhibition of myosin motor activity , 2009, Nature Structural &Molecular Biology.

[188]  S. Baserga,et al.  The long unwinding road of RNA helicases. , 2007, Molecular cell.

[189]  K. Föhr,et al.  Decavanadate displaces inositol 1,4,5-trisphosphate (IP3) from its receptor and inhibits IP3 induced Ca2+ release in permeabilized pancreatic acinar cells. , 1991, Cell calcium.

[190]  H. Delves,et al.  Distribution of zinc amongst human serum globulins determined by gel filtration--affinity chromatography and atomic-absorption spectrophotometry. , 1984, The Analyst.

[191]  D. Crans,et al.  Interaction of rabbit muscle aldolase at high ionic strengths with vanadate and other oxoanions. , 1992, Biochemistry.

[192]  M. Hir A soluble 5'-nucleotidase in rat kidney. Stimulation by decavanadate. , 1991 .

[193]  D. Crans,et al.  Nonreductive interaction of vanadate with an enzyme containing a thiol group in the active site: glycerol-3-phosphate dehydrogenase. , 1991, Biochemistry.

[194]  Lisa A. Lambert,et al.  Molecular Evolution of the Transferrin Receptor/Glutamate Carboxypeptidase II Family , 2006, Journal of Molecular Evolution.

[195]  A Wlodawer,et al.  Nuclear magnetic resonance and neutron diffraction studies of the complex of ribonuclease A with uridine vanadate, a transition-state analogue. , 1985, Biochemistry.

[196]  B. Gopal,et al.  Conformational basis for substrate recruitment in protein tyrosine phosphatase 10D. , 2011, Biochemistry.

[197]  W. R. Harris,et al.  Equilibrium model for speciation of aluminum in serum. , 1992, Clinical chemistry.

[198]  J. Wedekind,et al.  Base ionization and ligand binding: how small ribozymes and riboswitches gain a foothold in a protein world. , 2011, Current opinion in structural biology.

[199]  Daniel Herschlag,et al.  Biological phosphoryl-transfer reactions: understanding mechanism and catalysis. , 2011, Annual review of biochemistry.

[200]  W. Plass Chiral and supramolecular model complexes for vanadium haloperoxidases: Host–guest systems and hydrogen bonding relays for vanadate species , 2011 .

[201]  I. Gibbons,et al.  Specific cleavage of dynein heavy chains by ultraviolet irradiation in the presence of ATP and vanadate. , 1986, The Journal of biological chemistry.

[202]  P. Aisen,et al.  Iron binding to horse spleen apoferritin: a vanadyl ENDOR spin probe study. , 1991, Biochemistry.

[203]  D. Lilley,et al.  Structure, folding and mechanisms of ribozymes. , 2005, Current opinion in structural biology.

[204]  Ivan Rayment,et al.  X-ray structure of the magnesium(II).ADP.vanadate complex of the Dictyostelium discoideum myosin motor domain to 1.9 A resolution. , 1996 .

[205]  A. Guskov,et al.  Structural diversity of ABC transporters , 2014, The Journal of general physiology.

[206]  Application of DFT methods to the study of the coordination environment of the VO2+ ion in V proteins , 2012, JBIC Journal of Biological Inorganic Chemistry.

[207]  K. Gekko,et al.  A novel vanadium reductase, Vanabin2, forms a possible cascade involved in electron transfer. , 2009, Biochimica et biophysica acta.

[208]  G. Micera,et al.  A quantitative study of the biotransformation of insulin-enhancing VO2+ compounds , 2010, JBIC Journal of Biological Inorganic Chemistry.

[209]  B. Stec,et al.  A Model of the Transition State in the Alkaline Phosphatase Reaction* , 1999, The Journal of Biological Chemistry.

[210]  Chasteen Nd,et al.  Nonequivalence of the metal binding sites in vanadyl-labeled human serum transferrin. , 1975, Biochemistry.

[211]  D. Manstein,et al.  Crystal structure of human myosin 1c--the motor in GLUT4 exocytosis: implications for Ca2+ regulation and 14-3-3 binding. , 2014, Journal of molecular biology.

[212]  J. Zuo,et al.  Vanadium-iron-sulfur clusters containing the cubane-type [VFe3S4] core unit: synthesis of a cluster with the topology of the PN cluster of nitrogenase. , 2003, Inorganic chemistry.

[213]  N. Chasteen,et al.  An electron paramagnetic resonance study of vanadyl(IV)-serum albumin complexes , 1976 .

[214]  D. Rehder The Bioinorganic Chemistry of Vanadium , 1991 .

[215]  A. Ferré-D’Amaré,et al.  Transition State Stabilization by a Catalytic RNA , 2002, Science.

[216]  J. K. Grady,et al.  Characterization of the binding, kinetics, and redox stability of vanadium(IV) and vanadium(V) protein complexes in serum , 1986 .

[217]  C. Geraldes,et al.  Uptake and metabolic effects of insulin mimetic oxovanadium compounds in human erythrocytes. , 2005, Journal of inorganic biochemistry.

[218]  Sohei Yamamoto,et al.  Metal ion selectivity of the vanadium(V)-reductase Vanabin2. , 2013, Dalton transactions.

[219]  N. Chasteen,et al.  Metal ion complexes of apoferritin. Evidence for initial binding in the hydrophilic channels. , 1986, The Journal of biological chemistry.

[220]  Michael Y. Galperin,et al.  A superfamily of metalloenzymes unifies phosphopentomutase and cofactor‐independent phosphoglycerate mutase with alkaline phosphatases and sulfatases , 1998, Protein science : a publication of the Protein Society.

[221]  H. Sakurai,et al.  Specific binding of vanadyl ion (VO2+) with thiolate of the cysteine-34 residue in serum albumin, demonstrated by CD spectroscopy and kinetic property , 2003 .

[222]  Bradley S. Moore,et al.  A stereoselective vanadium-dependent chloroperoxidase in bacterial antibiotic biosynthesis. , 2011, Journal of the American Chemical Society.

[223]  G. Micera,et al.  Formation of new non-oxido vanadium(IV) species in aqueous solution and in the solid state by tridentate (O, N, O) ligands and rationalization of their EPR behavior. , 2013, Inorganic chemistry.

[224]  R. F. Campbell,et al.  An anion binding study of vanadyl(IV) human serotransferrin. Evidence for direct linkage to the metal. , 1977, The Journal of biological chemistry.

[225]  W G Hol,et al.  A model for the mechanism of human topoisomerase I. , 1998, Science.

[226]  M. Mahroof-Tahir,et al.  X-ray Structure of (NH4)6(Gly-Gly)2V10O28.cntdot.4H2O: Model Studies for Polyoxometalate-Protein Interactions , 1994 .

[227]  P. Sadler,et al.  Rationalisation of metal binding to transferrin: Prediction of metal-protein stability constants , 1997 .

[228]  W. Casey,et al.  Decavanadate, decaniobate, tungstate and molybdate interactions with sarcoplasmic reticulum Ca(2+)-ATPase: quercetin prevents cysteine oxidation by vanadate but does not reverse ATPase inhibition. , 2012, Dalton transactions.

[229]  Clyde A. Smith,et al.  Complexes of human lactoferrin with vanadium in oxidation states +3, +4 and +5 , 1995 .

[230]  B. Sarkar,et al.  Amino Terminal Cu(II)- and Ni(II)-Binding (ATCUN) Motif of Proteins and Peptides: Metal Binding, DNA Cleavage, and Other Properties† , 1997 .

[231]  R. Brenk,et al.  The small molecule tool (S)-(-)-blebbistatin: novel insights of relevance to myosin inhibitor design. , 2008, Organic & biomolecular chemistry.

[232]  S. Robson,et al.  Possible Effects of Microbial Ecto-Nucleoside Triphosphate Diphosphohydrolases on Host-Pathogen Interactions , 2008, Microbiology and Molecular Biology Reviews.

[233]  P. Pedersen,et al.  Novel Insights into the Chemical Mechanism of ATP Synthase , 1997, The Journal of Biological Chemistry.

[234]  M. Zhou,et al.  Overexpression, site-directed mutagenesis, and mechanism of Escherichia coli acid phosphatase. , 1992, The Journal of biological chemistry.

[235]  R. Vanholder,et al.  Fractionation of vanadium complexes in serum, packed cells and tissues of Wistar rats by means of gel filtration and anion-exchange chromatography , 2002, JBIC Journal of Biological Inorganic Chemistry.

[236]  P. Sadler,et al.  Interdomain zinc site on human albumin , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[237]  J. Wedekind,et al.  A comparison of vanadate to a 2'-5' linkage at the active site of a small ribozyme suggests a role for water in transition-state stabilization. , 2007, RNA.

[238]  A. Tracey,et al.  Interaction of vanadate with uridine and adenosine monophosphate. Formation of ADP and ATP analogs , 1988 .

[239]  J. Champoux,et al.  Novel insights into catalytic mechanism from a crystal structure of human topoisomerase I in complex with DNA. , 2000, Biochemistry.

[240]  P. Sadler,et al.  A new structural transition of serum albumin dependent on the state of Cys34. Detection by 1H-NMR spectroscopy. , 1994, European journal of biochemistry.

[241]  J. Champoux,et al.  RNase H activity: structure, specificity, and function in reverse transcription. , 2008, Virus research.

[242]  A. Tracey Hydroxamido vanadates: aqueous chemistry and function in protein tyrosine phosphatases and cell cultures. , 2000, Journal of inorganic biochemistry.

[243]  D. Rees,et al.  ABC transporters: the power to change , 2009, Nature Reviews Molecular Cell Biology.

[244]  B. Gopal,et al.  Conformational basis for substrate recognition and regulation of catalytic activity in Staphylococcus aureus nucleoside di-phosphate kinase. , 2011, Biochimica et biophysica acta.

[245]  Chasteen Nd Vanadium-protein interactions. , 1995 .

[246]  A. Sanz-Medel,et al.  Complementary FPLC-ICP-MS and MALDI-TOF for studying vanadium association to human serum proteins , 2005 .

[247]  P. Dimroth,et al.  Unique rotary ATP synthase and its biological diversity. , 2008, Annual review of biophysics.

[248]  A. Saha,et al.  Vanadate monomers and dimers both inhibit the human prostatic acid phosphatase. , 1989, Biochemical and biophysical research communications.

[249]  D. Crans,et al.  The chemistry and biochemistry of vanadium and the biological activities exerted by vanadium compounds. , 2004, Chemical reviews.

[250]  J. Sévigny,et al.  The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance , 2006, Purinergic Signalling.

[251]  Lisa A Lambert,et al.  Evolution of duplications in the transferrin family of proteins. , 2005, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology.

[252]  A. Messerschmidt,et al.  X-ray structures of apo and tungstate derivatives of vanadium chloroperoxidase from the fungus Curvularia inaequalis , 1998 .

[253]  M. F. White,et al.  Mechanistic implications for Escherichia coli cofactor-dependent phosphoglycerate mutase based on the high-resolution crystal structure of a vanadate complex. , 2002, Journal of molecular biology.

[254]  J. Casey,et al.  Vanadyl(IV) conalbumin. I. Metal binding site configurations , 1980 .

[255]  R. Ramasamy,et al.  Vanadate interactions with bovine copper,zinc-superoxide dismutase as probed by vanadium-51 NMR spectroscopy , 1991 .

[256]  Romaidi,et al.  Vanadium accumulation in ascidians : A system overview , 2015 .

[257]  R. Eady Current status of structure function relationships of vanadium nitrogenase , 2003 .

[258]  D. Crans,et al.  Interaction of trace levels of vanadium(IV) and vanadium(V) in biological systems , 1989 .

[259]  M. Romão,et al.  Interaction of vanadium(IV) with human serum apo-transferrin. , 2013, Journal of inorganic biochemistry.

[260]  J. Champoux,et al.  Crystal structure of a transition state mimic for Tdp1 assembled from vanadate, DNA, and a topoisomerase I-derived peptide. , 2003, Chemistry & biology.

[261]  C. Trachsel,et al.  Human Blood Plasma Proteins: Structure and Function , 2008 .

[262]  V. Simplaceanu,et al.  Assessment of roles of surface histidyl residues in the molecular basis of the Bohr effect and of beta 143 histidine in the binding of 2,3-bisphosphoglycerate in human normal adult hemoglobin. , 1999, Biochemistry.

[263]  J. Moura,et al.  Decavanadate interactions with actin: inhibition of G-actin polymerization and stabilization of decameric vanadate. , 2006, Journal of inorganic biochemistry.

[264]  P J Sadler,et al.  Transferrin as a metal ion mediator. , 1999, Chemical reviews.

[265]  V. Pecoraro,et al.  Modeling the biological chemistry of vanadium: Structural and reactivity studies elucidating biological function , 1997 .

[266]  Ronald T. Raines,et al.  Decavanadate inhibits catalysis by ribonuclease A. , 2000, Archives of biochemistry and biophysics.

[267]  A. Tracey,et al.  Vanadium: Chemistry, Biochemistry, Pharmacology and Practical Applications , 2007 .

[268]  Zihua Hu,et al.  Anti-diabetic effects of a series of vanadium dipicolinate complexes in rats with streptozotocin-induced diabetes. , 2011, Coordination chemistry reviews.

[269]  S. Loubéry,et al.  Membrane traffic in the secretory pathway , 2008, Cellular and Molecular Life Sciences.

[270]  A. F. Neuwald An unexpected structural relationship between integral membrane phosphatases and soluble haloperoxidases , 1997, Protein science : a publication of the Protein Society.

[271]  Edward N. Baker,et al.  Apolactoferrin structure demonstrates ligand-induced conformational change in transferrins , 1990, Nature.

[272]  G. Carman,et al.  Identification of a novel phosphatase sequence motif , 1997, Protein science : a publication of the Protein Society.

[273]  J. Sellers,et al.  Mechanism of Blebbistatin Inhibition of Myosin II* , 2004, Journal of Biological Chemistry.

[274]  J. K. Grady,et al.  Vanadyl(IV) binding to mammalian ferritins. An EPR study aided by site-directed mutagenesis. , 2000, Journal of inorganic biochemistry.

[275]  A. Wlodawer,et al.  Active site of RNase: neutron diffraction study of a complex with uridine vanadate, a transition-state analog. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[276]  Sean J. Johnson,et al.  Impaired acid catalysis by mutation of a protein loop hinge residue in a YopH mutant revealed by crystal structures. , 2009, Journal of the American Chemical Society.

[277]  M. W. Makinen,et al.  The Structural Basis of Action of Vanadyl (VO2+) Chelates in Cells. , 2014, Coordination chemistry reviews.

[278]  K. Thompson Coordination chemistry of vanadium in metallopharmaceutical candidate compounds , 2001 .

[279]  R. W. Collier Particulate and dissolved vanadium in the North Pacific Ocean , 1984, Nature.

[280]  S. Nair,et al.  Structural and mechanistic insights into C-P bond hydrolysis by phosphonoacetate hydrolase. , 2011, Chemistry & biology.

[281]  H. Vilter Peroxidases from phaeophyceae: A vanadium(V)-dependent peroxidase from Ascophyllum nodosum , 1984 .

[282]  G. George,et al.  X-ray absorption of Azotobacter vinelandii vanadium nitrogenase , 1988 .

[283]  J. Champoux,et al.  Explorations of peptide and oligonucleotide binding sites of tyrosyl-DNA phosphodiesterase using vanadate complexes. , 2004, Journal of medicinal chemistry.

[284]  A. Tracey,et al.  The characterization of primary, secondary, and tertiary vanadate alkyl esters by 51V nuclear magnetic resonance spectroscopy , 1988 .

[285]  G. Micera,et al.  Complex formation in aqueous solution and in the solid state of the potent insulin-enhancing V(IV)O2+ compounds formed by picolinate and quinolinate derivatives. , 2011, Inorganic chemistry.

[286]  K. Lau,et al.  Phosphotyrosyl protein phosphatases. , 1989, The Biochemical journal.

[287]  F. Bushman,et al.  Insights from the structure of a smallpox virus topoisomerase-DNA transition state mimic. , 2010, Structure.

[288]  G Schneider,et al.  Crystal structures of rat acid phosphatase complexed with the transition-state analogs vanadate and molybdate. Implications for the reaction mechanism. , 1994, European journal of biochemistry.

[289]  Kushol Gupta,et al.  Requirements for catalysis in the Cre recombinase active site , 2010, Nucleic acids research.

[290]  U Heinemann,et al.  Three-dimensional structure of the ribonuclease T1 2'-GMP complex at 1.9-A resolution. , 1988, The Journal of biological chemistry.

[291]  C. Orvig,et al.  Design of vanadium compounds as insulin enhancing agents , 2000 .

[292]  T. Otake,et al.  Intracellular localization of vanadium in the fan worm Pseudopotamilla occelata , 1994 .

[293]  I. Macara,et al.  Accumulation of vanadium by tunicate blood cells occurs via a specific anion transport system , 1981 .

[294]  M. Sebastián,et al.  The alkaline phosphatase PhoX is more widely distributed in marine bacteria than the classical PhoA , 2009, The ISME Journal.

[295]  Ting Xu,et al.  Crystal Structure of the NS3 Protease-Helicase from Dengue Virus , 2007, Journal of Virology.

[296]  L. Cantley,et al.  Vanadate inhibits the red cell (Na+, K+) ATPase from the cytoplasmic side , 1978, Nature.

[297]  P. Drake,et al.  Peroxovanadium compounds: Biolgoical actions and mechanism of insulin-mimesis , 1995, Molecular and Cellular Biochemistry.

[298]  I. Rayment,et al.  The structural basis of blebbistatin inhibition and specificity for myosin II , 2005, Nature Structural &Molecular Biology.

[299]  R. Wever,et al.  Peroxidase and Phosphatase Activity of Active-site Mutants of Vanadium Chloroperoxidase from the Fungus Curvularia inaequalis , 2000, The Journal of Biological Chemistry.

[300]  P. Hulley,et al.  Regulation of tyrosine phosphorylation cascades by phosphatases: What the actions of vanadium teach us , 2003 .

[301]  S. Phillips,et al.  Sulphate ions observed in the 2.12 A structure of a new crystal form of S. cerevisiae phosphoglycerate mutase provide insights into understanding the catalytic mechanism. , 1999, Journal of molecular biology.

[302]  G. Micera,et al.  Interaction of VO2+ ion and some insulin-enhancing compounds with immunoglobulin G. , 2011, Inorganic chemistry.

[303]  G. Micera,et al.  Transport of the anti-diabetic VO2+ complexes formed by pyrone derivatives in the blood serum. , 2012, Journal of inorganic biochemistry.

[304]  M. F. White,et al.  High Resolution Structure of the Phosphohistidine-activated Form of Escherichia coli Cofactor-dependent Phosphoglycerate Mutase* , 2001, The Journal of Biological Chemistry.

[305]  B. Künzli,et al.  Characterization of a monoclonal antibody as the first specific inhibitor of human NTP diphosphohydrolase‐3 , 2009, The FEBS journal.

[306]  H. Sakurai,et al.  Biospeciation of antidiabetic VO(IV) complexes , 2008 .

[307]  Jue Chen,et al.  Structural insights into ABC transporter mechanism. , 2008, Current opinion in structural biology.

[308]  E. Westhof,et al.  A three-dimensional model for the hammerhead ribozyme based on fluorescence measurements. , 1994, Science.

[309]  A. Meden,et al.  Synthesis and characterization of V(IV)O complexes of picolinate and pyrazine derivatives. Behavior in the solid state and aqueous solution and biotransformation in the presence of blood plasma proteins. , 2014, Inorganic chemistry.

[310]  D. C. Harris Different metal-binding properties of the two sites of human transferrin. , 1977, Biochemistry.

[311]  A. Wlodawer,et al.  Crystal Structures of the Semireduced and Inhibitor-bound Forms of Cyclic Nucleotide Phosphodiesterase from Arabidopsis thaliana * 210 , 2002, The Journal of Biological Chemistry.

[312]  L. Cantley,et al.  Glutathione reduces cytoplasmic vanadate. Mechanism and physiological implications. , 1980, Biochimica et biophysica acta.

[313]  G. Micera,et al.  Temperature and solvent structure dependence of VO2+ complexes of pyridine-N-oxide derivatives and their interaction with human serum transferrin. , 2012, Dalton transactions.

[314]  B. Sankaran,et al.  P-glycoprotein Is Stably Inhibited by Vanadate-induced Trapping of Nucleotide at a Single Catalytic Site (*) , 1995, The Journal of Biological Chemistry.

[315]  T. Drakenberg,et al.  Cadmium(II), zinc(II), and copper(II) ions binding to bovine serum albumin. A 113Cd NMR study , 1982 .

[316]  N. Chasteen,et al.  A Q-band electron paramagnetic resonance study of vanadyl(IV)-labeled human serotransferrin , 1979 .

[317]  T. Ueki,et al.  Vanadium-binding protein in a vanadium-rich ascidian Ascidia sydneiensissamea: CW and pulsed EPR studies. , 2003, Journal of the American Chemical Society.

[318]  M. Zhou,et al.  Crystal structure of bovine low molecular weight phosphotyrosyl phosphatase complexed with the transition state analog vanadate. , 1997, Biochemistry.

[319]  M. Wösten,et al.  Functional analysis of a Campylobacter jejuni alkaline phosphatase secreted via the Tat export machinery. , 2008, Microbiology.

[320]  P. Bevilacqua,et al.  Nucleobase catalysis in ribozyme mechanism. , 2006, Current opinion in chemical biology.

[321]  Francesco Luigi Gervasio,et al.  DFT modeling of biological systems , 2006 .

[322]  J. V. Van Beeumen,et al.  Respiration and Growth of Shewanella oneidensis MR-1 Using Vanadate as the Sole Electron Acceptor , 2005, Journal of bacteriology.

[323]  H. Sakurai,et al.  Structural and redox requirements for the action of anti-diabetic vanadium compounds. , 2014, Dalton transactions.

[324]  L. Prade,et al.  Implications for the Catalytic Mechanism of the Vanadium-Containing Enzyme Chloroperoxidase from the Fungus Curvularia inaequalis by X-Ray Structures of the Native and Peroxide Form , 1997, Biological chemistry.

[325]  H. Sakurai,et al.  Orally active and long-term acting insulin-mimetic vanadyl complex:bis(picolinato)oxovanadium (IV). , 1995, Biochemical and biophysical research communications.

[326]  T. Whiteside,et al.  Increased Ectonucleotidase Expression and Activity in Regulatory T Cells of Patients with Head and Neck Cancer , 2009, Clinical Cancer Research.

[327]  Anne Houdusse,et al.  Structural and functional insights into the Myosin motor mechanism. , 2010, Annual review of biophysics.

[328]  Miriam,et al.  Recent advances in vanadium catalyzed oxygen transfer reactions , 2011 .

[329]  P. Martel,et al.  Binding modes of decavanadate to myosin and inhibition of the actomyosin ATPase activity. , 2007, Biochimica et biophysica acta.

[330]  Elizabeth C. Theil,et al.  Iron binding by horse spleen apoferritin. A vanadyl(IV) EPR spin probe study. , 1982, The Journal of biological chemistry.

[331]  L. Beaugé [23] Inhibition of translocation reactions by vanadate , 1988 .

[332]  Somnath Roy,et al.  New insights on vanadium binding to human serum transferrin , 2014 .

[333]  B. Mikami,et al.  Crystal structure of diferric hen ovotransferrin at 2.4 A resolution. , 1995, Journal of molecular biology.

[334]  T. Kiss,et al.  Binding of Oxovanadium(IV) Complexes to Blood Serum Albumins , 2017 .

[335]  J. Aaseth,et al.  The effect of chelating agents on vanadium distribution in the rat body and on uptake by human erythrocytes , 1982, Archives of Toxicology.

[336]  A. Salifoglou,et al.  The chemistry and biology of vanadium compounds in cancer therapeutics , 2015 .

[337]  V. Pecoraro,et al.  Assessing the dependence of (51)V A(z) value on the aromatic ring orientation of V(IV)O(2+) pyridine complexes. , 2009, Inorganic chemistry.

[338]  T. Ueki,et al.  High Levels of Vanadium in Ascidians , 2012 .

[339]  J. Poznański,et al.  Spectroscopic and thermodynamic determination of three distinct binding sites for Co(II) ions in human serum albumin. , 2009, Journal of inorganic biochemistry.

[340]  S. Everse,et al.  The Crystal Structure of Iron-free Human Serum Transferrin Provides Insight into Inter-lobe Communication and Receptor Binding* , 2006, Journal of Biological Chemistry.

[341]  S. Eaton,et al.  Comparison of the electron spin echo envelope modulation (ESEEM) for human lactoferrin and transferrin complexes of copper(II) and vanadyl ion. , 1989, The Journal of biological chemistry.

[342]  L. Pedersen,et al.  The Sulfuryl Transfer Mechanism , 1998, The Journal of Biological Chemistry.

[343]  A. Butler,et al.  Vanadium-51 NMR as a probe of vanadium(V) coorination to human apotransferrin , 1989 .

[344]  G. Micera,et al.  New developments in the comprehension of the biotransformation and transport of insulin-enhancing vanadium compounds in the blood serum. , 2010, Inorganic chemistry.

[345]  L. F. Hass,et al.  2,3-diphosphoglycerate phosphatase activity of phosphoglycerate mutase: stimulation by vanadate and phosphate. , 1987, Biochemistry.

[346]  G. Willsky,et al.  Is vanadate reduced by thiols under biological conditions? Changing the redox potential of V(V)/V(IV) by complexation in aqueous solution. , 2010, Inorganic chemistry.

[347]  D. Crans,et al.  Vanadate tetramer as the inhibiting species in enzyme reactions in vitro and in vivo , 1990 .

[348]  M. Aureliano Vanadate oligomer inhibition of passive and active Ca2+ translocation by the Ca2+ pump of sarcoplasmic reticulum. , 2000, Journal of inorganic biochemistry.

[349]  D. Barford,et al.  Crystal structure of human protein tyrosine phosphatase 1B. , 1994, Science.

[350]  D. Rehder The potentiality of vanadium in medicinal applications. , 2012, Future medicinal chemistry.

[351]  Haiwei Luo,et al.  Subcellular localization of marine bacterial alkaline phosphatases , 2009, Proceedings of the National Academy of Sciences.

[352]  M. F. White,et al.  The two analogous phosphoglycerate mutases of Escherichia coli , 1999, FEBS letters.

[353]  K. Gekko,et al.  Characterization of vanadium-binding sites of the vanadium-binding protein Vanabin2 by site-directed mutagenesis. , 2009, Biochimica et biophysica acta.

[354]  J. Pessoa,et al.  Transport of therapeutic vanadium and ruthenium complexes by blood plasma components. , 2010, Current medicinal chemistry.

[355]  J. Krahn,et al.  Structure of an Aprataxin–DNA complex with insights into AOA1 Neurodegenerative Disease , 2011, Nature Structural &Molecular Biology.

[356]  Subhash G. Vasudevan,et al.  Crystal Structure of the Dengue Virus RNA-Dependent RNA Polymerase Catalytic Domain at 1.85-Angstrom Resolution , 2007, Journal of Virology.

[357]  N. Sträter,et al.  Crystallographic evidence for a domain motion in rat nucleoside triphosphate diphosphohydrolase (NTPDase) 1. , 2012, Journal of molecular biology.

[358]  P. Holliger,et al.  Ribozyme-Catalyzed Transcription of an Active Ribozyme , 2011, Science.

[359]  T. Kuzuyama,et al.  Characterization of the fomA andfomB Gene Products from Streptomyces wedmorensis, Which Confer Fosfomycin Resistance on Escherichia coli , 2000, Antimicrobial Agents and Chemotherapy.

[360]  K. Locher,et al.  Structure of AMP-PNP-bound vitamin B12 transporter BtuCD–F , 2012, Nature.

[361]  Wei Yang,et al.  Stepwise analyses of metal ions in RNase H catalysis from substrate destabilization to product release , 2006, The EMBO journal.

[362]  A. Knowles The GDA1_CD39 superfamily: NTPDases with diverse functions , 2011, Purinergic Signalling.

[363]  Arieh Warshel,et al.  Why nature really chose phosphate , 2013, Quarterly Reviews of Biophysics.

[364]  M. Aureliano,et al.  Interactions of vanadate oligomers with sarcoplasmic reticulum Ca(2+)-ATPase. , 1994, Biochimica et biophysica acta.

[365]  U. Heinemann,et al.  Crystal structure of guanosine-free ribonuclease T1, complexed with vanadate (V), suggests conformational change upon substrate binding. , 1989, Biochemistry.

[366]  Y. Asano,et al.  X‐ray structures of a novel acid phosphatase from Escherichia blattae and its complex with the transition‐state analog molybdate , 2000, The EMBO journal.

[367]  P. Harrison,et al.  The ferritins: molecular properties, iron storage function and cellular regulation. , 1996, Biochimica et biophysica acta.

[368]  I. Lamont,et al.  Crystal structures of Escherichia coli uridine phosphorylase in two native and three complexed forms reveal basis of substrate specificity, induced conformational changes and influence of potassium. , 2004, Journal of molecular biology.

[369]  J. Tanner,et al.  Structure of Francisella tularensis AcpA , 2006, Journal of Biological Chemistry.

[370]  K. Locher,et al.  Asymmetric states of vitamin B12 transporter BtuCD are not discriminated by its cognate substrate binding protein BtuF , 2012, FEBS letters.

[371]  H. Sweeney,et al.  The Structural Basis for the Large Powerstroke of Myosin VI , 2007, Cell.

[372]  M. Vieth,et al.  Kinomics-structural biology and chemogenomics of kinase inhibitors and targets. , 2004, Biochimica et biophysica acta.

[373]  D. Barrio,et al.  Interactions of vanadyl(IV) with dithiothreitol and thioglycolic acid. Their action on alkaline phosphatase activity , 1999 .

[374]  K. Locher,et al.  Asymmetry in the Structure of the ABC Transporter-Binding Protein Complex BtuCD-BtuF , 2007, Science.

[375]  D. Rehder The future of/for vanadium. , 2013, Dalton transactions.

[376]  D. Manstein,et al.  Mechanism and Specificity of Pentachloropseudilin-mediated Inhibition of Myosin Motor Activity , 2011, The Journal of Biological Chemistry.

[377]  D. Barrio,et al.  On the interaction of the vanadyl(IV) cation with lactose , 2007, Biological Trace Element Research.

[378]  H. Tajmir-Riahi,et al.  Interaction of human serum albumin with oxovanadium ions studied by FT-IR spectroscopy and gel and capillary electrophoresis , 2001 .

[379]  T. Kiss,et al.  The systems VIVO2+-glutathione and related ligands: a potentiometric and spectroscopic study , 2002, JBIC Journal of Biological Inorganic Chemistry.

[380]  J. Sowadski,et al.  Refined structure of alkaline phosphatase from Escherichia coli at 2.8 A resolution. , 1985, Journal of molecular biology.

[381]  N. Sträter,et al.  Cellular function and molecular structure of ecto-nucleotidases , 2012, Purinergic Signalling.

[382]  B. Annabi,et al.  Transmembrane Topology of Glucose-6-Phosphatase* , 1998, The Journal of Biological Chemistry.

[383]  Daniele Sanna,et al.  Interaction of insulin-enhancing vanadium compounds with human serum holo-transferrin. , 2013, Inorganic chemistry.

[384]  D. Rehder,et al.  The medicinal and catalytic potential of model complexes of vanadate-dependent haloperoxidases , 2003 .

[385]  L. Josephson,et al.  Isolation of a potent (Na-K)ATPase inhibitor from striated muscle. , 1977, Biochemistry.

[386]  J. McMurray,et al.  A1 H spin echo and 51V NMR study of the interaction of vanadate with intact erythrocytes , 1997, JBIC Journal of Biological Inorganic Chemistry.

[387]  C. Post,et al.  The oxyvanadium constellation in transition-state-analogue complexes of phosphoglucomutase and ribonuclease. Structural deductions from electron-transfer spectra. , 1990, Biochemistry.

[388]  J. G. Kuenen,et al.  New enzyme belonging to the family of molybdenum-free nitrate reductases. , 2003, The Biochemical journal.

[389]  H. Dekker,et al.  From phosphatases to vanadium peroxidases: a similar architecture of the active site. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[390]  C. Haynes,et al.  Calorimetric studies of the interaction between the insulin-enhancing drug candidate bis(maltolato)oxovanadium(IV) (BMOV) and human serum apo-transferrin. , 2009, Journal of inorganic biochemistry.

[391]  M. Aureliano,et al.  Ion pumps as biological targets for decavanadate. , 2013, Dalton transactions.

[392]  Joseph Bertolini,et al.  Transferrin: structure, function and potential therapeutic actions. , 2005, Drug discovery today.

[393]  H. Sakurai,et al.  Speciation of insulin-mimetic VO(IV)-containing drugs in blood serum. , 2000, Journal of inorganic biochemistry.

[394]  Arata Yoji,et al.  Mn2+-probe ESR method for the analyses of the dissociation of charged residues on the surface of immunoglobulins. , 1986 .

[395]  Geoffrey Chang,et al.  Flexibility in the ABC transporter MsbA: Alternating access with a twist , 2007, Proceedings of the National Academy of Sciences.

[396]  Jue Chen,et al.  Structure, Function, and Evolution of Bacterial ATP-Binding Cassette Systems , 2008, Microbiology and Molecular Biology Reviews.

[397]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[398]  L. Delage,et al.  The Vanadium Iodoperoxidase from the Marine Flavobacteriaceae Species Zobellia galactanivorans Reveals Novel Molecular and Evolutionary Features of Halide Specificity in the Vanadium Haloperoxidase Enzyme Family , 2014, Applied and Environmental Microbiology.

[399]  Chasteen Nd,et al.  Metal site conformational states of vanadyl(IV) human serotransferrin complexes. , 1977 .

[400]  N. Kelleher,et al.  Heterologous production of fosfomycin and identification of the minimal biosynthetic gene cluster. , 2006, Chemistry & biology.

[401]  L M Amzel,et al.  The 2.8-A structure of rat liver F1-ATPase: configuration of a critical intermediate in ATP synthesis/hydrolysis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[402]  C. Supuran,et al.  ESI mass spectrometry and X-ray diffraction studies of adducts between anticancer platinum drugs and hen egg white lysozyme. , 2007, Chemical communications.

[403]  J. Moura,et al.  Decavanadate as a biochemical tool in the elucidation of muscle contraction regulation. , 2004, Journal of inorganic biochemistry.

[404]  C. Goodno Inhibition of myosin ATPase by vanadate ion. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[405]  D. Barford,et al.  Visualization of the Cysteinyl-phosphate Intermediate of a Protein-tyrosine Phosphatase by X-ray Crystallography* , 1998, The Journal of Biological Chemistry.

[406]  S. Buchanan,et al.  A structural comparison of human serum transferrin and human lactoferrin , 2007, BioMetals.

[407]  Decavanadate binding to a high affinity site near the myosin catalytic centre inhibits F-actin-stimulated myosin ATPase activity. , 2004 .

[408]  W. Filipowicz,et al.  Cloning and Characterization of the ArabidopsisCyclic Phosphodiesterase Which Hydrolyzes ADP-ribose 1",2"-Cyclic Phosphate and Nucleoside 2′,3′-Cyclic Phosphates* , 1997, The Journal of Biological Chemistry.

[409]  Jue Chen,et al.  Snapshots of the maltose transporter during ATP hydrolysis , 2011, Proceedings of the National Academy of Sciences.

[410]  B. Akabayov,et al.  Vanadate in structural biology , 2014 .

[411]  T. R. Gilbert,et al.  Vanadium and other metal ions in the physiological ecology of marine organisms , 1983 .

[412]  A. Messerschmidt,et al.  X-ray structure of a vanadium-containing enzyme: chloroperoxidase from the fungus Curvularia inaequalis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[413]  J. H. Viles,et al.  1H and (113)Cd NMR Investigations of Cd(2+) and Zn(2+) Binding Sites on Serum Albumin: Competition with Ca(2+), Ni(2+), Cu(2+), and Zn(2+). , 1996, Inorganic chemistry.

[414]  M. Battell,et al.  Vanadium compounds as insulin mimics. , 1999, Metal ions in biological systems.

[415]  A. Ferré-D’Amaré,et al.  Crystal structure of a hairpin ribozyme–inhibitor complex with implications for catalysis , 2001, Nature.

[416]  Clive R. Bagshaw,et al.  Insights into the Importance of Hydrogen Bonding in the γ-Phosphate Binding Pocket of Myosin: Structural and Functional Studies of Serine 236†,‡ , 2010, Biochemistry.

[417]  L. Josephson,et al.  A characterization of vanadate interactions with the (Na,K)-ATPase. Mechanistic and regulatory implications. , 1978, The Journal of biological chemistry.

[418]  D. Fattorini,et al.  Hyperaccumulation of vanadium in the Antarctic polychaete Perkinsiana littoralis as a natural chemical defense against predation , 2010, Environmental science and pollution research international.

[419]  J. Casey,et al.  Vanadyl(IV) conalbumin. II. Mixed metal and anion binding studies , 1980 .

[420]  A. Wlodawer,et al.  Structure and mechanism of activity of the cyclic phosphodiesterase of Appr>p, a product of the tRNA splicing reaction , 2000, The EMBO journal.

[421]  M. Kollmar,et al.  Crystal structure of the motor domain of a class‐I myosin , 2002, The EMBO journal.

[422]  G. Grüber,et al.  Nucleotide binding states of subunit A of the A-ATP synthase and the implication of P-loop switch in evolution. , 2010, Journal of molecular biology.

[423]  T. Kiss,et al.  Vanadate complexes in serum: a speciation modeling study. , 2010, Dalton transactions.

[424]  A. N. Antipov,et al.  Vanadium‐Binding Protein Excreted by Vanadate‐Reducing Bacteria , 2000, IUBMB life.

[425]  Z. Zhang,et al.  Protein-tyrosine phosphatases: biological function, structural characteristics, and mechanism of catalysis. , 1998, Critical reviews in biochemistry and molecular biology.

[426]  Gonçalo J. L. Bernardes,et al.  CORM-3 reactivity toward proteins: the crystal structure of a Ru(II) dicarbonyl-lysozyme complex. , 2011, Journal of the American Chemical Society.

[427]  R. Lancashire,et al.  Oxovanadium(IV) and amino acids—I. The system L-alanine+VO2+ ; a potentiometric and spectroscopic study , 1988 .

[428]  A. Davidson,et al.  Vanadate-Induced Trapping of Nucleotides by Purified Maltose Transport Complex Requires ATP Hydrolysis , 2000, Journal of bacteriology.

[429]  R. Warner,et al.  Vanadate is a potent (Na,K)-ATPase inhibitor found in ATP derived from muscle. , 1977, The Journal of biological chemistry.

[430]  G. Micera,et al.  On the transport of vanadium in blood serum. , 2009, Inorganic chemistry.

[431]  B. Sankaran,et al.  Both P-glycoprotein Nucleotide-binding Sites Are Catalytically Active (*) , 1995, The Journal of Biological Chemistry.

[432]  H. Yoshida,et al.  The ribonuclease T1 family. , 2001, Methods in enzymology.

[433]  G. Micera,et al.  Application of DFT Methods in the Study of VIVO2+ -Peptide Interactions , 2010 .

[434]  S. Piersma,et al.  Cofactor and substrate binding to vanadium chloroperoxidase determined by UV-VIS spectroscopy and evidence for high affinity for pervanadate. , 2000, Biochemistry.

[435]  K. Kustin,et al.  Do vanadate polyanions inhibit phosphotransferase enzymes? , 1985, Biochimica et biophysica acta.

[436]  D. Rees,et al.  Nitrogenase MoFe-Protein at 1.16 Å Resolution: A Central Ligand in the FeMo-Cofactor , 2002, Science.

[437]  J. Tawara,et al.  A kinetic method for determination of free vanadium(IV) and (V) at trace level concentrations. , 1990, Analytical biochemistry.

[438]  H. Sakurai,et al.  Detection of vanadyl‐nitrogen interaction in organs of the vanadyl‐treated rat: electron spin echo envelope modulation study , 1995, FEBS letters.

[439]  Edmond Lam,et al.  New insights into the interactions of serum proteins with bis(maltolato)oxovanadium(IV): transport and biotransformation of insulin-enhancing vanadium pharmaceuticals. , 2005, Journal of the American Chemical Society.

[440]  G. Chaconas,et al.  The circle is broken: telomere resolution in linear replicons. , 2001, Current opinion in microbiology.

[441]  M. V. Nogués,et al.  Bovine pancreatic ribonuclease: fifty years of the first enzymatic reaction mechanism. , 2011, Biochemistry.

[442]  E. Jankowsky,et al.  RNA helicases--one fold for many functions. , 2007, Current opinion in structural biology.

[443]  J. Champoux,et al.  The structure of the transition state of the heterodimeric topoisomerase I of Leishmania donovani as a vanadate complex with nicked DNA. , 2006, Journal of molecular biology.

[444]  T. Kiss,et al.  The system VO2+ +oxidized glutathione: a potentiometric and spectroscopic study. , 2001, Journal of inorganic biochemistry.

[445]  Robert J.P. Williams,et al.  The Chemistry of Evolution: The Development of our Ecosystem , 2005 .

[446]  H. R. Evans,et al.  C3 exoenzyme from Clostridium botulinum: structure of a tetragonal crystal form and a reassessment of NAD-induced flexure. , 2004, Acta crystallographica. Section D, Biological crystallography.